The Importance of Growth Hormone (GH) and GH Secretagogues for Bone Mass and Density
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2023-2032
Author(s):
Johan Svensson
SERMs: Evolutionary Chemistry, Revolutionary Biology
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2089-2111
Author(s):
Chris P. Miller
Technetium Labeled Small Peptide Radiopharmaceuticals in the Identification of Lung Cancer
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1827-1836
Author(s):
Jay Blum, Hirsch Handmaker and Neal A. Rinne
Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1765-1780
Author(s):
Eric J. Friedman
Transductional Targeting with Recombinant Adenovirus Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
323-339
Author(s):
Valerie Legrand, Philippe Leissner, Arend Winter, Majid Mehtali and Monika Lusky
Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
379-392
Author(s):
O. Mazda
Pharmacogenomics Opportunities in Nuclear Receptor Targeted Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
243-256
Author(s):
M. Schapira
Telomerase Inhibitors as Anticancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
567-575
Author(s):
Masaharu Akiyama, Teru Hideshima, Nikhil C. Munshi and Kenneth C. Anderson
Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
605-612
Author(s):
M. Folini, M. Pennati and N. Zaffaroni
How to Inhibit Telomerase Activity for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
613-626
Author(s):
Satoru Kyo and Masaki Inoue